Literature DB >> 24805322

Antibiotic resistance sweeping developing world.

Sara Reardon.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24805322     DOI： 10.1038/509141a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  38 in total

Review 1.  Antibiotic use and emerging resistance: how can resource-limited countries turn the tide?

Authors:  Lisa M Bebell; Anthony N Muiru
Journal:  Glob Heart       Date:  2014-10-31

Review 2.  Antibiotics in the clinical pipeline at the end of 2015.

Authors:  Mark S Butler; Mark At Blaskovich; Matthew A Cooper
Journal:  J Antibiot (Tokyo)       Date:  2016-06-29       Impact factor: 2.649

Review 3.  Looking Backward To Move Forward: the Utility of Sequencing Historical Bacterial Genomes.

Authors:  Rebecca J Bennett; Kate S Baker
Journal:  J Clin Microbiol       Date:  2019-07-26       Impact factor: 5.948

Review 4.  High-quality health systems in the Sustainable Development Goals era: time for a revolution.

Authors:  Margaret E Kruk; Anna D Gage; Catherine Arsenault; Keely Jordan; Hannah H Leslie; Sanam Roder-DeWan; Olusoji Adeyi; Pierre Barker; Bernadette Daelmans; Svetlana V Doubova; Mike English; Ezequiel García-Elorrio; Frederico Guanais; Oye Gureje; Lisa R Hirschhorn; Lixin Jiang; Edward Kelley; Ephrem Tekle Lemango; Jerker Liljestrand; Address Malata; Tanya Marchant; Malebona Precious Matsoso; John G Meara; Manoj Mohanan; Youssoupha Ndiaye; Ole F Norheim; K Srinath Reddy; Alexander K Rowe; Joshua A Salomon; Gagan Thapa; Nana A Y Twum-Danso; Muhammad Pate
Journal:  Lancet Glob Health       Date:  2018-09-05       Impact factor: 26.763

5.  Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.

Authors:  Jatan Bahadur Sherchan; Kayoko Hayakawa; Tohru Miyoshi-Akiyama; Norio Ohmagari; Teruo Kirikae; Maki Nagamatsu; Masayoshi Tojo; Hiroshi Ohara; Jeevan B Sherchand; Sarmila Tandukar
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

6.  Synthesis of octapeptin C4 and biological profiling against NDM-1 and polymyxin-resistant bacteria.

Authors:  Bernd Becker; Mark S Butler; Karl A Hansford; Alejandra Gallardo-Godoy; Alysha G Elliott; Johnny X Huang; David J Edwards; Mark A T Blaskovich; Matthew A Cooper
Journal:  Bioorg Med Chem Lett       Date:  2017-04-12       Impact factor: 2.823

7.  Occurrence and distribution of selected antibiotics in the surface waters and ecological risk assessment based on the theory of natural disaster.

Authors:  Sijia Li; Hanyu Ju; Jiquan Zhang; Peng Chen; Meichen Ji; Jianhua Ren; Shuyun Zhao
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-02       Impact factor: 4.223

8.  Detection and genotype analysis of AmpC β-lactamase in Klebsiella pneumoniae from tertiary hospitals.

Authors:  Xiang-Qun Liu; Yong-Rui Liu
Journal:  Exp Ther Med       Date:  2016-04-27       Impact factor: 2.447

9.  MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88.

Authors:  C Benito-Villalvilla; C Cirauqui; C M Diez-Rivero; M Casanovas; J L Subiza; O Palomares
Journal:  Mucosal Immunol       Date:  2016-12-14       Impact factor: 7.313

Review 10.  Understanding treatment guidelines with bismuth and non-bismuth quadruple Helicobacter pylori eradication therapies.

Authors:  David Y Graham; Maria Pina Dore; Hong Lu
Journal:  Expert Rev Anti Infect Ther       Date:  2018-08-23       Impact factor: 5.091
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.